Sort Results:

List of Partnerships

Argenta and ANTABIO Announce Drug Discovery Collaboration


Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, announced today that it has achieved a milestone with its collaboration pa...

Partner: ANTABIO
Academic Institute/Non-Profit: Wellcome Trust

Astra Zeneca and Broad Institute to Co-develop Antiviral and Antibacterial Drugs


Broad Institute and Astrza Zeneca have entered into a two year collaboration agreement to co-develop antiviral and antibacterial drugs. Screening and target hit to lead chemistry will take place at Broa...

Partner: Astra Zeneca
Academic Institute/Non-Profit: Broad Institute

Astra Zeneca and University of Pennsylvania Partner to Develop Treatments to Manage Obesity


Astra Zeneca has entered into a research collaboration agreement with University of Pennsylvania's Institute for Diabetes, Obesity and Metabolism to develop small and or large molecules to manage obesity, ...

Partner: Astra Zeneca
Academic Institute/Non-Profit: University of Pennsylvania's Institute for Diabetes, Obesity and Metabolism

Bayer and UCSF Enter into a 10year Research & Development Partnership


Bayer and University of California, San Francisco (UCSF) have signed a 10year master research and development agreement. The agreement provides a broad template for collaboration between the two groups...

Partner: Bayer
Academic Institute/Non-Profit: University of California, San Francisco (UCSF)

Brigham & Woman's Hospital and Sanofi to Partner in Type 1 Diabetes Space


Sanofi and Brigham & Woman's Hospital an affiliate of Harvard University have entered into a joint collaboration to develop new drugs based on novel immunomodulatory approach to treat Type 1 Diabetes. ...

Partner: Sanofi
Academic Institute/Non-Profit: Brigham & Woman's Hospital



 Share resources for the discovery of new drugs stemming rom CDRD and IPS.

Partner: Center for Drug Research and Development
Academic Institute/Non-Profit: Non-profit



development of peptide therapeutics to metastatic cancer

Partner: Joyce A. Schroeder
Academic Institute/Non-Profit: University of Arizona Cancer Center

Cerecor Partners with Johns Hopkins Brain Science Institute to Treat Schizophrenia


Cerecor a Baltimore based company has taken an option with Johns Hopkins University to license D-Amino Acid Oxidase inhibitors (DAAO) to treat Schizophrenia. The DAAO inhibitor molecules are currently b...

Partner: Cerecor
Academic Institute/Non-Profit: Johns Hopkins Brain Science Institute ("BSi")

Creative BioMart


Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecu...

Partner: Creative BioMart
Academic Institute/Non-Profit: Creative BioMart

CWHM/OWH Childhood Diarrhea


CWHM signed a joint research agreement in 2010 with the Institute for One World Health to discover and develop new drugs to combat diarrhea, which is the second leading cause of death worldwide in children...

Partner: PATH/One World Health
Academic Institute/Non-Profit: CWHM at Saint Louis University